ESPERION THERAPEUTICS INC (ESPR) Stock Cash Flow
NASDAQ:ESPR - Nasdaq - US29664W1053 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -153.22M | -51.74M | -209.25M | -233.66M | -269.11M | |||
| Depreciation Amortization | 89.00K | 63.00K | 164.00K | 500.00K | 610.00K | |||
| Change In Working Capital | -26.70M | -60.53M | 13.68M | -3.37M | -52.51M | |||
| Other non cash items | 79.72M | 88.56M | 59.92M | 61.71M | 57.20M | |||
| OPERATING CASH FLOW | -100.11M | -23.65M | -135.49M | -174.83M | -263.81M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -244.00K | -317.00K | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | 42.50M | 8.10M | -50.48M | |||
| INVESTING CASH FLOW | -244.00K | -317.00K | 42.50M | 8.10M | -50.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 35.01M | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 9.55M | 105.99M | 65.97M | 90.85M | 222.45M | |||
| Other Financing Activity | -56.19M | -54.52M | -15.51M | -58.24M | 45.77M | |||
| FINANCING CASH FLOW | -11.62M | 86.48M | 50.46M | 32.61M | 268.22M | |||
| CHANGE IN CASH | -111.98M | 62.51M | -42.53M | -134.12M | -46.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -100.11M | -23.65M | -135.49M | -174.83M | -263.81M | |||
| Capital Expenditure | -244.00K | -317.00K | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -100.35M | -23.97M | -135.49M | -174.83M | -263.81M | |||
All data in USD